COVID-19 Presentation Public Health 
Bill of Health
FEBRUARY 14, 2023
By Katherine Macfarlane Public health in the U.S. This essay describes the cost of casting aside what is best for the public’s health in favor of individual choice, especially to those who are high-risk for serious illness or death from COVID-19. In other words, public health is a group project.
Bill of Health
NOVEMBER 7, 2023
Yet when COVID-19 – the greatest health emergency in a century – devastated the world, the Siracusa Principles seemed unequal to the task – too narrow, including with their remit limited to civil and political rights, not sufficiently specific, and above all, without sufficient accountability.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare It News
FEBRUARY 3, 2025
While decentralized clinical trials began emerging before the COVID-19 pandemic, the public health crisis accelerated the trend. Since we last spoke about the clinic’s strategy for decentralized clinical trials (a presentation at HIMSS23), how has the program progressed?
Bill of Health
SEPTEMBER 11, 2023
Remote accommodations were granted freely during the first year of the COVID-19 pandemic, but in 2021, the in-person aspect of teaching and learning was suddenly deemed essential, and at many institutions, remote classes came to an end. That same medication rendered him high-risk for severe illness or death from COVID-19.
Bill of Health
OCTOBER 12, 2022
Although politicians and pundits warned that businesses would drown in a “ tidal wave ” of lawsuits seeking to hold them liable for COVID-19 infections, plaintiffs face significant barriers to recovery. At the time of the lunch, both were COVID-19 positive. However, B knew she was COVID-19 positive.
Bill of Health
NOVEMBER 8, 2022
In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. The post What Happened to the COVID-19 Vaccine Patent Waiver?
Bill of Health
FEBRUARY 24, 2023
By Taleed El-Sabawi The use of emergency public health powers by state and local governments during the first months of the COVID-19 pandemic led to intense public criticism followed by legislative attempts (include some successes) to strip state executives of this authority. What does the future hold?
Expert insights. Personalized for you.
340 
Let's personalize your content